COLL Competitors & Alternatives

Compare Collegium Pharmaceutical Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

COLL

Main Stock
$27.11
Tradestie Score
56
Market Cap
$1.11B
P/E Ratio
21.7
Revenue Growth
0.1%
Analyst Upside
+83.0%

Top Competitors

44 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
XERS Xeris Biopharma Holdings, Inc. Common Stock
$8.70
$1.29B - 41 Compare
AMPH Amphastar Pharmaceuticals, Inc.
$21.60
$1.25B 12.8 37 Compare
DVAX Dynavax Technologies Corporation
$15.50
$1.21B - 48 Compare
INVA Innoviva, Inc. Common Stock
$21.07
$1.15B 5.0 45 Compare
PCRX Pacira BioSciences, Inc. Common Stock
$24.67
$1.14B 67.7 59 Compare
CRON Cronos Group Inc. Common Share
$3.31
$1.02B 16.9 33 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$4.66
$711.32M - 35 Compare
ESPR Esperion Therapeutics, Inc.
$3.18
$584.71M - 53 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$63.47
$543.32M 157.7 40 Compare
EOLS Evolus, Inc. Common Stock
$8.39
$397.82M - 27 Compare

Data updated: Aug 23, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

44 stocks in this industry